Therapeutic applications of lipid-coated microbubbles

Evan C. Unger, Thomas Richard Porter, William Culp, Rachel Labell, Terry Matsunaga, Reena Zutshi

Research output: Contribution to journalArticle

433 Citations (Scopus)

Abstract

Lipid-coated microbubbles represent a new class of agents with both diagnostic and therapeutic applications. Microbubbles have low density. Stabilization of microbubbles by lipid coatings creates low-density particles with unusual properties for diagnostic imaging and drug delivery. Perfluorocarbon (PFC) gases entrapped within lipid coatings make microbubbles that are sufficiently stable for circulation in the vasculature as blood pool agents. Microbubbles can be cavitated with ultrasound energy for site-specific local delivery of bioactive materials and for treatment of vascular thrombosis. The blood-brain barrier (BBB) can be reversibly opened without damaging the neurons using ultrasound applied across the intact skull to cavitate microbubbles within the cerebral microvasculature for delivery of both low and high molecular weight therapeutic compounds to the brain. The first lipid-coated PFC microbubble product is currently marketed for diagnostic ultrasound imaging. Clinical trials are currently in process for treatment of vascular thrombosis with ultrasound and lipid-coated PFC microbubbles (SonoLysis™ Therapy). Targeted microbubbles and acoustically active PFC nanoemulsions with specific ligands can be developed for detecting disease at the molecular level and targeted drug and gene delivery. Bioactive compounds can be incorporated into these carriers for site-specific delivery. Our aim is to cover the therapeutic applications of lipid-coated microbubbles and PFC emulsions in this review.

Original languageEnglish (US)
Pages (from-to)1291-1314
Number of pages24
JournalAdvanced Drug Delivery Reviews
Volume56
Issue number9
DOIs
StatePublished - May 7 2004

Fingerprint

Microbubbles
Lipids
Fluorocarbons
Therapeutics
Diagnostic Imaging
Blood Vessels
Ultrasonography
Thrombosis
Microvessels
Emulsions
Blood-Brain Barrier
Skull
Pharmaceutical Preparations
Molecular Weight
Gases
Clinical Trials
Ligands
Neurons

Keywords

  • Blood-brain barrier
  • Cavitation
  • Clot lysis
  • Drug delivery
  • Emulsions
  • Gene delivery
  • Lipid
  • Microbubbles
  • Microspheres
  • Perfluorocarbon
  • Sonothrombolysis
  • Ultrasound

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Unger, E. C., Porter, T. R., Culp, W., Labell, R., Matsunaga, T., & Zutshi, R. (2004). Therapeutic applications of lipid-coated microbubbles. Advanced Drug Delivery Reviews, 56(9), 1291-1314. https://doi.org/10.1016/j.addr.2003.12.006

Therapeutic applications of lipid-coated microbubbles. / Unger, Evan C.; Porter, Thomas Richard; Culp, William; Labell, Rachel; Matsunaga, Terry; Zutshi, Reena.

In: Advanced Drug Delivery Reviews, Vol. 56, No. 9, 07.05.2004, p. 1291-1314.

Research output: Contribution to journalArticle

Unger, EC, Porter, TR, Culp, W, Labell, R, Matsunaga, T & Zutshi, R 2004, 'Therapeutic applications of lipid-coated microbubbles', Advanced Drug Delivery Reviews, vol. 56, no. 9, pp. 1291-1314. https://doi.org/10.1016/j.addr.2003.12.006
Unger, Evan C. ; Porter, Thomas Richard ; Culp, William ; Labell, Rachel ; Matsunaga, Terry ; Zutshi, Reena. / Therapeutic applications of lipid-coated microbubbles. In: Advanced Drug Delivery Reviews. 2004 ; Vol. 56, No. 9. pp. 1291-1314.
@article{d339c5b066954133b9dc286962eaf751,
title = "Therapeutic applications of lipid-coated microbubbles",
abstract = "Lipid-coated microbubbles represent a new class of agents with both diagnostic and therapeutic applications. Microbubbles have low density. Stabilization of microbubbles by lipid coatings creates low-density particles with unusual properties for diagnostic imaging and drug delivery. Perfluorocarbon (PFC) gases entrapped within lipid coatings make microbubbles that are sufficiently stable for circulation in the vasculature as blood pool agents. Microbubbles can be cavitated with ultrasound energy for site-specific local delivery of bioactive materials and for treatment of vascular thrombosis. The blood-brain barrier (BBB) can be reversibly opened without damaging the neurons using ultrasound applied across the intact skull to cavitate microbubbles within the cerebral microvasculature for delivery of both low and high molecular weight therapeutic compounds to the brain. The first lipid-coated PFC microbubble product is currently marketed for diagnostic ultrasound imaging. Clinical trials are currently in process for treatment of vascular thrombosis with ultrasound and lipid-coated PFC microbubbles (SonoLysis™ Therapy). Targeted microbubbles and acoustically active PFC nanoemulsions with specific ligands can be developed for detecting disease at the molecular level and targeted drug and gene delivery. Bioactive compounds can be incorporated into these carriers for site-specific delivery. Our aim is to cover the therapeutic applications of lipid-coated microbubbles and PFC emulsions in this review.",
keywords = "Blood-brain barrier, Cavitation, Clot lysis, Drug delivery, Emulsions, Gene delivery, Lipid, Microbubbles, Microspheres, Perfluorocarbon, Sonothrombolysis, Ultrasound",
author = "Unger, {Evan C.} and Porter, {Thomas Richard} and William Culp and Rachel Labell and Terry Matsunaga and Reena Zutshi",
year = "2004",
month = "5",
day = "7",
doi = "10.1016/j.addr.2003.12.006",
language = "English (US)",
volume = "56",
pages = "1291--1314",
journal = "Advanced Drug Delivery Reviews",
issn = "0169-409X",
publisher = "Elsevier",
number = "9",

}

TY - JOUR

T1 - Therapeutic applications of lipid-coated microbubbles

AU - Unger, Evan C.

AU - Porter, Thomas Richard

AU - Culp, William

AU - Labell, Rachel

AU - Matsunaga, Terry

AU - Zutshi, Reena

PY - 2004/5/7

Y1 - 2004/5/7

N2 - Lipid-coated microbubbles represent a new class of agents with both diagnostic and therapeutic applications. Microbubbles have low density. Stabilization of microbubbles by lipid coatings creates low-density particles with unusual properties for diagnostic imaging and drug delivery. Perfluorocarbon (PFC) gases entrapped within lipid coatings make microbubbles that are sufficiently stable for circulation in the vasculature as blood pool agents. Microbubbles can be cavitated with ultrasound energy for site-specific local delivery of bioactive materials and for treatment of vascular thrombosis. The blood-brain barrier (BBB) can be reversibly opened without damaging the neurons using ultrasound applied across the intact skull to cavitate microbubbles within the cerebral microvasculature for delivery of both low and high molecular weight therapeutic compounds to the brain. The first lipid-coated PFC microbubble product is currently marketed for diagnostic ultrasound imaging. Clinical trials are currently in process for treatment of vascular thrombosis with ultrasound and lipid-coated PFC microbubbles (SonoLysis™ Therapy). Targeted microbubbles and acoustically active PFC nanoemulsions with specific ligands can be developed for detecting disease at the molecular level and targeted drug and gene delivery. Bioactive compounds can be incorporated into these carriers for site-specific delivery. Our aim is to cover the therapeutic applications of lipid-coated microbubbles and PFC emulsions in this review.

AB - Lipid-coated microbubbles represent a new class of agents with both diagnostic and therapeutic applications. Microbubbles have low density. Stabilization of microbubbles by lipid coatings creates low-density particles with unusual properties for diagnostic imaging and drug delivery. Perfluorocarbon (PFC) gases entrapped within lipid coatings make microbubbles that are sufficiently stable for circulation in the vasculature as blood pool agents. Microbubbles can be cavitated with ultrasound energy for site-specific local delivery of bioactive materials and for treatment of vascular thrombosis. The blood-brain barrier (BBB) can be reversibly opened without damaging the neurons using ultrasound applied across the intact skull to cavitate microbubbles within the cerebral microvasculature for delivery of both low and high molecular weight therapeutic compounds to the brain. The first lipid-coated PFC microbubble product is currently marketed for diagnostic ultrasound imaging. Clinical trials are currently in process for treatment of vascular thrombosis with ultrasound and lipid-coated PFC microbubbles (SonoLysis™ Therapy). Targeted microbubbles and acoustically active PFC nanoemulsions with specific ligands can be developed for detecting disease at the molecular level and targeted drug and gene delivery. Bioactive compounds can be incorporated into these carriers for site-specific delivery. Our aim is to cover the therapeutic applications of lipid-coated microbubbles and PFC emulsions in this review.

KW - Blood-brain barrier

KW - Cavitation

KW - Clot lysis

KW - Drug delivery

KW - Emulsions

KW - Gene delivery

KW - Lipid

KW - Microbubbles

KW - Microspheres

KW - Perfluorocarbon

KW - Sonothrombolysis

KW - Ultrasound

UR - http://www.scopus.com/inward/record.url?scp=1942486333&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1942486333&partnerID=8YFLogxK

U2 - 10.1016/j.addr.2003.12.006

DO - 10.1016/j.addr.2003.12.006

M3 - Article

C2 - 15109770

AN - SCOPUS:1942486333

VL - 56

SP - 1291

EP - 1314

JO - Advanced Drug Delivery Reviews

JF - Advanced Drug Delivery Reviews

SN - 0169-409X

IS - 9

ER -